Skip to main content

Curis Inc

CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001108205

No open-market purchases or sales by Curis Inc insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $7.96M in total; Maverick Capital is the only superinvestor holding it.

Q4 2025 vs. Q3 2025

How the institutions holding Curis Inc changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of CRIS: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders41410
Shares4.61M4.33M−282.0K (−6.1%)
Value$7.58M$4.23M−$3.35M (−44.2%)

New holders (5)

Institutions that held Curis Inc at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to CRIS in Q4 2025
InstitutionSharesValue% of portfolio
Stonepine Capital Management, LLC59,349$58.6K0.05%
Citadel Advisors LLC47,247$46.6K0.00%
XTX Topco Ltd25,867$25.5K0.00%
Susquehanna International Group, LLP19,277$19.0K0.00%
DRW Securities, LLC17,646$17.4K0.00%

Sold out (5)

Institutions that held Curis Inc at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of CRIS in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Virtu Financial LLC10,337$17.0K
Northwestern Mutual Wealth Management Co8$13
CIBC Private Wealth Group, LLC6$10
Barclays PLC1$2
TruNorth Capital Management, LLC1$2